Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Operating Expenses | 3,166 | 1,869 | 1,410 | 2,075 | 903 |
| Operating Income | -3,166 | -1,869 | -1,410 | -2,075 | -903 |
| Other Income | 4,513 | 1,249 | 4,199 | -1,108 | 777 |
| Pre-tax Income | 1,347 | -620 | 2,790 | -3,183 | -126 |
| Net Income Continuous | 1,347 | -620 | 2,790 | -3,183 | -126 |
| Net Income | $1,347 | $-620 | $2,790 | $-3,183 | $-126 |
| EPS Basic Total Ops | -0.35 | -0.65 | -0.26 | -0.54 | -0.02 |
| EPS Basic Continuous Ops | 0.04 | -0.07 | 0.32 | -0.25 | -0.02 |
| EPS Diluted Total Ops | -0.35 | -0.65 | -0.26 | -0.54 | -0.02 |
| EPS Diluted Continuous Ops | 0.04 | -0.07 | 0.32 | -0.25 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -0.65 | -0.64 | N/A | N/A |
| EBITDA(a) | $-3,166 | $-1,869 | $-1,410 | $-2,075 | $-903 |